Eligibility Depression NCT00643162

1 Formulieren

StudyEvent: Eligibility
1. Eligibility Depression NCT00643162

Name

Type

Description | Question | Decode (Coded Value)

Datatype

Alias

Inclusion Criteria

Item Group

C1512693 (UMLS CUI)

Age

Item

1. > 60 years of age

boolean

C0001779 (UMLS CUI [1])

Unipolar major depression

Item

2. unipolar major depression as defined by structured clinical interaction dsm-iv (scid)

boolean

C1269683 (UMLS CUI [1])

Hamilton Rating Scale

Item

3. ham-d score of > 17 (21-item scale)]]

boolean

C0451203 (UMLS CUI [1])

Antidepressive Therapy

Item

4. not taking antidepressants for at least two weeks, 2 months for fluoxetine and maois]]

boolean

C0003289 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])

Informed Consent

Item

5. capable of giving informed consent.

boolean

C0021430 (UMLS CUI [1])

Exclusion Criteria

Item Group

C0680251 (UMLS CUI)

Unable to give informed consent

Item

1. unable to provide informed consent (e.g. severe cognitive impairment)

boolean

C1299582 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])

Medical condition requiring medical treatment

Item

2. acute medical condition or exacerbation of chronic medical condition associated with significant distress (pain, protracted fevers, etc.) and requiring active medical treatment.

boolean

C0012634 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])

High risk of suicide

Item

3. high risk of suicide or violence as assessed by the investigator

boolean

C1271074 (UMLS CUI [1])

Psychosis or bipolar disorder

Item

4. current or past history of psychosis or bipolar disorder

boolean

C0033975 (UMLS CUI [1])
C0005586 (UMLS CUI [2])

Psychotropic medication and/or psychotherapy

Item

5. use of psychotropic medication and/or psychotherapy outside of the study

boolean

C0033978 (UMLS CUI [1])
C0033968 (UMLS CUI [2])

Pharmacotherapy

Item

6. (exposure to treatment of fluoxetine or maois in the previous two months; chronic use of benzodiazepine and non-benzodiazepine sedatives, antipsychotics, psychostimulants, mood stabilizing agents, codeine, steroids, anti-inflammatory agents.

boolean

C0013216 (UMLS CUI [1])

Alternative medicine

Item

7. alternative medicine use in the preceding 30 days (e.g. acupuncture, herbs, etc.)

boolean

C0002346 (UMLS CUI [1])

Contraindication to massage

Item

8. history of intolerance to massage or contraindication to massage (e.g. skin lesions that prevent direct contact by the therapist)

boolean

C0024875 (UMLS CUI [1,1])
C1301624 (UMLS CUI [1,2])

Mental disorder

Item

9. diagnosis of schizophrenia, schizophreniform disorder, schizoaffective disorder, schizotypal disorder, psychotic depression or bipolar disorders;

boolean

C0004936 (UMLS CUI [1])

MMSE

Item

10. mmse less than 22

boolean

C0451306 (UMLS CUI [1])

Alzheimer's disease assessment

Item

11. alzheimer's disease assessment scale-cognitive subscale ³ greater than 12

boolean

C0002395 (UMLS CUI [1])

Substance Use Disorder

Item

12. current drug or alcohol abuse or dependence or history of drug or alcohol abuse or dependence within the past 6 months

boolean

C0038586 (UMLS CUI [1])

Unstable status

Item

13. unstable medical or neurological conditions that are likely to interfere with the treatment of depression

boolean

C0443343 (UMLS CUI [1])

Psychotropic pharmacotherapy

Item

14. currently on psychotropic medications including antidepressants or neuroleptics

boolean

C0033978 (UMLS CUI [1])

Safety issue

Item

15. active suicidal ideation or other safety issues determined by the clinician to not be suitable for inclusion in the study

boolean

C2911688 (UMLS CUI [1])

Terug naar het begin van de pagina

ID

Beschrijving

Link

Trefwoorden

Versies (1)

Geüploaded op

DOI

Licentie

Model Commentaren :

Itemgroep Commentaren voor :

Item Commentaren voor :

Eligibility Depression NCT00643162